ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 47 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,275,000 | +14.0% | 167,756 | -0.3% | 0.27% | +6.8% |
| Q2 2018 | $1,996,000 | -52.5% | 168,187 | -55.0% | 0.25% | -54.7% |
| Q1 2018 | $4,200,000 | +620.4% | 374,017 | +328.4% | 0.55% | +616.9% |
| Q4 2017 | $583,000 | -2.5% | 87,307 | +19.6% | 0.08% | -4.9% |
| Q3 2017 | $598,000 | -30.6% | 72,996 | -62.0% | 0.08% | -34.1% |
| Q2 2017 | $862,000 | +283.1% | 192,045 | +371.0% | 0.12% | +251.4% |
| Q1 2017 | $225,000 | -54.3% | 40,772 | -32.7% | 0.04% | -58.3% |
| Q1 2016 | $492,000 | – | 60,575 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |